Ankerstar Wealth’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$188K Buy
6,580
+74
+1% +$1.97K 0.15% 79
2026
Q2
$157K Sell
6,506
-22
-0.3% -$575 0.13% 82
2026
Q1
$183K Buy
6,528
+2,308
+55% +$61.4K 0.19% 69
2025
Q4
$105K Buy
+4,220
New +$106K 0.1% 99

Other funds holding PFE

Ankerstar Wealth's PFE Position: Q3 2026 in Review

Ankerstar Wealth increased its Pfizer (PFE) stake by 1.1% in Q3 2026, buying an estimated $1.97K and bringing the position to 6,580 shares worth $188K. The position accounts for 0.15% of the portfolio, ranked #79.

Ankerstar Wealth first reported a position in PFE in Q4 2025 and has held it in 4 quarters since. 2,915 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • Ankerstar Wealth held 6,580 shares of Pfizer worth $188K as of Q3 2026.
  • Ankerstar Wealth bought 74 Pfizer shares in Q3 2026, an estimated $1.97K.
  • Pfizer made up 0.15% of Ankerstar Wealth's portfolio in Q3 2026, its #79 holding.
  • Ankerstar Wealth first reported a position in Pfizer in Q4 2025 and has held it in 4 quarters since.
  • 2,915 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Ankerstar Wealth's 13F filing for Q3 2026, filed 13 Nov 2026.